Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Spectrum’s Fusilev Doesn’t Face Threat From Generics, CEO Shrotriya Says Q
Spectrum’s Fusilev Doesn’t Face Threat From Generics, CEO Shrotriya Says Q
Spectrum’s Fusilev Doesn’t Face Threat From Generics, CEO Shrotriya Says Q
Submitted by
admin
on December 10, 2011 - 12:38pm
Source:
Bloomberg
News Tags:
Fusilev
Spectrum Pharmaceuticals
generics
colon cancer
Headline:
Spectrum’s Fusilev Doesn’t Face Threat From Generics, CEO Shrotriya Says Q
Do Not Allow Advertisers to Use My Personal information
